- Home
- PLX vs CSHRW Comparison
PLX vs CSHRW Comparison
Compare PLX & CSHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.34
Company Overview
Basic Information| Metric | PLX | CSHRW |
|---|---|---|
| Founded | 1993 | N/A |
| Country | United States | Jersey |
| Employees | 226 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.9M | 167.4M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLX | CSHRW |
|---|---|---|
| Price | $2.34 | $0.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 489.5K | 5.4K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $52,744,000.00 | N/A |
| Revenue This Year | $36.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.32 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.42 | $0.52 |
| 52 Week High | $3.19 | $1.15 |
Technical Indicators
Market Signals| Indicator | PLX | CSHRW |
|---|---|---|
| Relative Strength Index (RSI) | 45.20 | 38.05 |
| Support Level | $2.25 | $0.55 |
| Resistance Level | $2.44 | $0.88 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 21.15 | 18.75 |
Price Performance
Historical Comparison PLX
CSHRW
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.